Literature DB >> 15280655

Elevated levels of thymidylate synthase linked to neoplastic transformation of mammalian cells.

Donna Voeller1, Lambratu Rahman, Maria Zajac-Kaye.   

Abstract

Thymidylate synthase (TS), an enzyme that is essential for DNA synthesis and repair has been identified as an important biomarker for colorectal and other human cancers. The elevated steady-state levels of TS found in many common human malignancies have been thought to represent a secondary event in tumor formation. However, it has recently been demonstrated that the deregulated levels of ectopic TS may also have a causal effect on tumorgenesis since overexpression of human TS transforms immortalized mammalian cells to a malignant phenotype. Since the levels of TS are regulated by E2F-1 and thus are linked to the cell cycle pathway, regulating TS activity may be an important factor for the control of cell cycle progression and for the development of therapeutic strategies and cancer prevention.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15280655

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  9 in total

1.  Thymidylate synthase polymorphism in sporadic colorectal and gastric cancer in Tunisian population: a predictive role in 5-fluorouracil based chemotherapy treatment.

Authors:  Olfa Baroudi; Thouraya Baroudi; Ines Omrane; Amel Moussa; Amel Mezlini; Hajer Ayari; Sami Guermazi; Abdesslem Bahloul; Hassen Bouzaienne; Nancy Uhrhammer; Yves Jean Bignon; Amel Benammar El-Gaaied; Karim Bougatef
Journal:  Med Oncol       Date:  2014-01-11       Impact factor: 3.064

Review 2.  Metabolic alterations and targeted therapies in prostate cancer.

Authors:  Richard Flavin; Giorgia Zadra; Massimo Loda
Journal:  J Pathol       Date:  2010-11-16       Impact factor: 7.996

3.  Erk5 contributes to maintaining the balance of cellular nucleotide levels and erythropoiesis.

Authors:  Maria Angulo-Ibáñez; Xavier Rovira-Clavé; Alba Granados-Jaén; Bradley Downs; Yeong C Kim; San Ming Wang; Manuel Reina; Enric Espel
Journal:  Cell Cycle       Date:  2015       Impact factor: 4.534

Review 4.  Nucleotide metabolism, oncogene-induced senescence and cancer.

Authors:  Katherine M Aird; Rugang Zhang
Journal:  Cancer Lett       Date:  2014-01-29       Impact factor: 8.679

5.  Direct role of nucleotide metabolism in C-MYC-dependent proliferation of melanoma cells.

Authors:  Sudha Mannava; Vladimir Grachtchouk; Linda J Wheeler; Michael Im; Dazhong Zhuang; Elena G Slavina; Christopher K Mathews; Donna S Shewach; Mikhail A Nikiforov
Journal:  Cell Cycle       Date:  2008-06-03       Impact factor: 4.534

6.  FASN Protein Overexpression Indicates Poor Biochemical Recurrence-Free Survival in Prostate Cancer.

Authors:  Zhi Cao; Yalong Xu; Fei Guo; Xi Chen; Jin Ji; Huan Xu; Jingyi He; Yongwei Yu; Yinghao Sun; Xin Lu; Fubo Wang
Journal:  Dis Markers       Date:  2020-06-18       Impact factor: 3.434

7.  3'UTR polymorphism of Thymidylate Synthase gene increased the risk of persistence of pre-neoplastic cervical lesions.

Authors:  Nayara Nascimento Toledo Silva; Ana Carolina Silva Santos; Verlândia Mendes Nogueira; Cláudia Martins Carneiro; Angélica Alves Lima
Journal:  BMC Cancer       Date:  2020-04-15       Impact factor: 4.430

8.  Raltitrexed Inhibits HepG2 Cell Proliferation via G0/G1 Cell Cycle Arrest.

Authors:  Hongwei Zhao; Yubao Zhang; Jianmin Sun; Chao Zhan; Liang Zhao
Journal:  Oncol Res       Date:  2016       Impact factor: 5.574

9.  Targeting Thymidylate Synthase Enhances the Chemosensitivity of Triple-Negative Breast Cancer Towards 5-FU-Based Combinatorial Therapy.

Authors:  Nair Hariprasad Haritha; Akbar Nawab; Vinod Vijayakurup; Nikhil Ponnoor Anto; Vijayasteltar B Liju; Vijai V Alex; Areekkara Nisthul Amrutha; Sreekumar U Aiswarya; Mundanattu Swetha; Balachandran S Vinod; Sankar Sundaram; Maria V Guijarro; Thomas Herlevich; Archana Krishna; Nesteena K Nestory; Smitha V Bava; Chittalakkottu Sadasivan; Maria Zajac-Kaye; Ruby John Anto
Journal:  Front Oncol       Date:  2021-07-15       Impact factor: 6.244

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.